ALPHA TEKNOVA, INC. Interest and Fee Income, Other Loans Held-for-sale
ALPHA TEKNOVA, INC. (TKNO) reported Interest and Fee Income, Other Loans Held-for-sale of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestAndFeeIncomeOtherLoansHeldForSale · last filed 2026-08-06
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for the quarter ending 2026-06-30 was $0.00.
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for the quarter ending 2025-12-31 was $0.00.
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for the quarter ending 2025-09-30 was $0.00.
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for fiscal 2025 was $485.00K.
- ALPHA TEKNOVA, INC. interest and fee income, other loans held-for-sale for fiscal 2024 was $0.00.
| Period end | Interest and Fee Income, Other Loans Held-for-sale 3 month | Interest and Fee Income, Other Loans Held-for-sale 6 month | Interest and Fee Income, Other Loans Held-for-sale 9 month | Interest and Fee Income, Other Loans Held-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $485.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $485.00K 10-Q · filed 2025-11-07 | $485.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $485.00K 10-Q · filed 2026-08-06 | $485.00K derived: sum of 3 quarters · filed 2026-08-06 | $485.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $485.00K 10-Q · filed 2026-05-07 | $485.00K derived: sum of 2 quarters · filed 2026-05-07 | $485.00K derived: sum of 3 quarters · filed 2026-05-07 | $485.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |